Wilder-Smith A - Search Results

1

Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis.

Young B, Zhao X, Cook AR, Parry CM, Wilder-Smith A, I-Cheng MC. Young B, et al. Vaccine. 2017 Jan 5;35(2):212-221. doi: 10.1016/j.vaccine.2016.11.013. Epub 2016 Dec 7. Vaccine. 2017. PMID: 27939013 Free article. Review.

2

Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies.

Young B, Sadarangani S, Jiang L, Wilder-Smith A, Chen MI. Young B, et al. J Infect Dis. 2018 Feb 14;217(5):731-741. doi: 10.1093/infdis/jix632. J Infect Dis. 2018. PMID: 29220496

3

The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: study protocol for a randomised clinical trial.

Young B, Sadarangani S, Yew HS, Yung CF, Leo YS, Chen MI, Wilder-Smith A. Young B, et al. Trials. 2017 Feb 10;18(1):67. doi: 10.1186/s13063-017-1808-8. Trials. 2017. PMID: 28183326 Free PMC article. Clinical Trial.

4

Influenza on cruise ships.

Young BE, Wilder-Smith A. Young BE, et al. J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay146. J Travel Med. 2018. PMID: 30649459 No abstract available.

5

Semiannual Versus Annual Influenza Vaccination in Older Adults in the Tropics: An Observer-blind, Active-comparator-controlled, Randomized Superiority Trial.

Young B, Sadarangani S, Haur SY, Yung CF, Barr I, Connolly J, Chen M, Wilder-Smith A. Young B, et al. Clin Infect Dis. 2019 Jun 18;69(1):121-129. doi: 10.1093/cid/ciy836. Clin Infect Dis. 2019. PMID: 30277500 Clinical Trial.

6

Differential Household Attack Rates Mirror the Ability to Control Coronavirus Disease 2019 (COVID-19).

Cook AR, Dickens BL, Wilder-Smith A. Cook AR, et al. Clin Infect Dis. 2021 Jun 15;72(12):e1166-e1167. doi: 10.1093/cid/ciaa1842. Clin Infect Dis. 2021. PMID: 33305788 Free PMC article. No abstract available.

7

Institutional versus home isolation to curb the COVID-19 outbreak - Authors' reply.

Wilder-Smith A, Cook AR, Dickens BL. Wilder-Smith A, et al. Lancet. 2020 Nov 21;396(10263):1632-1633. doi: 10.1016/S0140-6736(20)32171-1. Epub 2020 Nov 6. Lancet. 2020. PMID: 33166506 Free PMC article. No abstract available.

8

Institutional, not home-based, isolation could contain the COVID-19 outbreak.

Dickens BL, Koo JR, Wilder-Smith A, Cook AR. Dickens BL, et al. Lancet. 2020 May 16;395(10236):1541-1542. doi: 10.1016/S0140-6736(20)31016-3. Epub 2020 Apr 29. Lancet. 2020. PMID: 32423581 Free PMC article. No abstract available.

9

Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine.

Tambyah PA, Wilder-Smith A, Pavlova BG, Barrett PN, Oh HM, Hui DS, Yuen KY, Fritsch S, Aichinger G, Loew-Baselli A, van der Velden M, Maritsch F, Kistner O, Ehrlich HJ. Tambyah PA, et al. Vaccine. 2012 Jan 5;30(2):329-35. doi: 10.1016/j.vaccine.2011.10.088. Epub 2011 Nov 12. Vaccine. 2012. PMID: 22080174 Clinical Trial.

10

Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel.

Dickens BL, Koo JR, Lim JT, Sun H, Clapham HE, Wilder-Smith A, Cook AR. Dickens BL, et al. J Travel Med. 2020 Dec 23;27(8):taaa141. doi: 10.1093/jtm/taaa141. J Travel Med. 2020. PMID: 32841354 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

405 results

Search Page